Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details

This article is part of the supplement: 15th Paediatric Rheumatology European Society (PreS) Congress .

Open AccessPoster presentation

May antihistone antibodies replace antinuclear antibodies (ANA) as a predictor of uveitis in Juvenile idiopathic arthritis?

EB Nordal1, NT Songstad2, B Straume3, L Berntson4 and M Rygg5

Department of Pediatrics, University Hospital of North Norway and Institute of Community Medicine, University of Tromsø, Tromsø, Norway

Department of Pediatrics, University Hospital of North Norway, Tromsø, Norway

Institute of Community Medicine, University of Tromsø, Tromsø, Norway

Department of Women's and Children's Health, Uppsala University Children's Hospital, Uppsala, Sweden

Department of Laboratory Medicine, Children's and Women's Health, Norwegian University of Science and Technology and Department of Pediatrics, St. Olavs Hospital, Trondheim, Norway

corresponding author email

from 15th Paediatric Rheumatology European Society (PreS) Congress
London, UK. 14–17 September 2008

Pediatric Rheumatology 2008, 6(Suppl 1):P4doi:10.1186/1546-0096-6-S1-P4

Published: 15 September 2008

First paragraph (this article has no abstract)

Antihistone antibodies (AHA) are an ANA subtype reported to be associated with uveitis in Juvenile idiopathic arthritis (JIA). Enzyme-linked immunoassays (E-ANA) are increasingly used as a more standardized alternative to the immunofluorescense method on Hep-2 cells (IF-ANA). E-ANA, however, show no association with uveitis and should not be used in the diagnostic work-up of JIA.


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.